All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @natalieavni on TikTok · 47s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @natalieavni's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Let's talk about the blood test, what it is, and how it works.
  2. 0:02An IPT screens for any kind of chromosomal abnormalities, like Down syndrome, but also because it's
  3. 0:06a chromosomal analysis, it can figure out if you're having a boy or a girl.
  4. 0:10I highly encourage to get a done in around 11 weeks.
  5. 0:12I know some patients get a done in around 10, but I've just seen more accurate results.
  6. 0:16And I mean by accurate, sometimes you'll get the blood test a little too early and then
  7. 0:20it comes back inconclusive and then you have to retest.
  8. 0:22With my experience, we've been doing it for about six years here.
  9. 0:25I haven't seen anything come back wrong, but I haven't seen it come back inconclusive when
  10. 0:29the patient goes too early.
  11. 0:30I think overall it's a great thing to do just because it's an early screening and you get
  12. 0:35to find out the gender early, why not?
  13. 0:37Did I hear stories on the internet where they said that they had it wrong?
  14. 0:39Yes, but I personally haven't.
  15. 0:41Regardless, when I scan my patients, once I see the gender, I always ask them if they
  16. 0:45want to know and I confirm it for them.

TikTok ultrasound tech's blood test claims, fact-checked

Natalie | That Ultrasound Tech

TikTok creator

958.1K viewsWatch on TikTok

Quick answer

NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA from a maternal blood draw and is clinically validated for both chromosomal aneuploidy screening and fetal sex chromosome identification after 10 weeks gestation. The creator's timing recommendation of 11 weeks aligns with published guidance on optimizing fetal fraction adequacy. However, fetal sex misidentification, while rare, is documented in the literature and is most commonly associated with low fetal fraction, vanishing twin syndrome, or maternal sex chromosome mosaicism rather than lab error.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 3 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TikTok ultrasound tech's blood test claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TikTok ultrasound tech's blood test claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TikTok ultrasound tech's blood test claims, fact-checked" from Natalie | That Ultrasound Tech. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA from a maternal blood draw and is clinically validated for both chromosomal aneuploidy screening and fetal sex chromosome identification after 10 weeks gestation.

The reason this review is not generic is the source wording and the canonical claim label "trt replying to courtneybarnard3 my take on the gender results." In this clip, the useful excerpt is: "Let's talk about the blood test, what it is, and how it works." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The most common cause of incorrect NIPT sex results is not lab failure.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA from a maternal blood draw and is clinically validated for both chromosomal aneuploidy screening and fetal sex chromosome identification after 10 weeks gestation.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • NIPT (non-invasive prenatal testing) analyzes cell-free fetal DNA from a maternal blood draw and is clinically validated for both chromosomal aneuploidy screening and fetal sex chromosome identification after 10 weeks gestation. The creator's timing recommendation of 11 weeks aligns with published guidance on optimizing fetal fraction adequacy. However, fetal sex misidentification, while rare, is documented in the literature and is most commonly associated with low fetal fraction, vanishing twin syndrome, or maternal sex chromosome mosaicism rather than lab error.
  • NIPT fetal sex accuracy exceeds 98% after 10 weeks gestation per a 2019 systematic review by Meng et al. in Ultrasound in Obstetrics and Gynecology, but that still leaves a measurable error rate.
  • The most common cause of incorrect NIPT sex results is not lab failure. It is low fetal fraction, vanishing twin syndrome, or maternal sex chromosome mosaicism per Hartwig et al., 2021, Prenatal Diagnosis.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • NIPT fetal sex accuracy exceeds 98% after 10 weeks gestation per a 2019 systematic review by Meng et al. in Ultrasound in Obstetrics and Gynecology, but that still leaves a measurable error rate.
  • The most common cause of incorrect NIPT sex results is not lab failure. It is low fetal fraction, vanishing twin syndrome, or maternal sex chromosome mosaicism per Hartwig et al., 2021, Prenatal Diagnosis.
  • ACOG considers a fetal fraction below 4% the primary driver of no-call results, which is why testing before 10 weeks increases the chance of an inconclusive report.
  • NIPT is a screening tool, not a diagnostic test. Chromosomal abnormality findings require confirmation via amniocentesis or CVS before clinical decisions are made.
  • Fetal sex identified by NIPT reflects chromosomal sex (XX or XY) and is not a statement about gender identity.
  • Insurance coverage for NIPT in low-risk pregnancies varies widely. Patients should confirm coverage before ordering the test to avoid unexpected out-of-pocket costs.
  • An ultrasound confirmation of fetal sex at the 18 to 20 week anatomy scan remains standard practice and serves as an independent check on NIPT sex results.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @natalieavni actually say?

The creator, who identifies as an ultrasound tech with six years of experience, explains that a non-invasive prenatal test (NIPT) screens for chromosomal abnormalities like Down syndrome and can also determine fetal sex. She recommends waiting until around 11 weeks to get the test, arguing that testing at 10 weeks or earlier can produce inconclusive results. She states she personally has never seen a wrong gender result from the test, though she acknowledges hearing about errors online. She also describes confirming fetal sex via ultrasound once she can visualize it.

The video is framed as a response to a follower question and draws primarily on personal clinical observation rather than published research. That framing matters when evaluating what she says.

Does the science back this up?

Mostly, yes, but with important caveats she glosses over. NIPT is highly accurate for fetal sex determination, but "highly accurate" is not the same as "never wrong."

A 2015 meta-analysis by Devaney et al. in Genetics in Medicine, covering over 3,000 pregnancies, found NIPT fetal sex determination had a sensitivity of 95.8% and specificity of 98.9% for male identification. A 2019 systematic review by Meng et al. in Ultrasound in Obstetrics and Gynecology confirmed accuracy rates above 98% when testing occurred after 10 weeks of gestation. The timing recommendation around 10 to 11 weeks is supported by data: fetal cell-free DNA (cfDNA) fractions are lower before 10 weeks, which increases the rate of inconclusive or failed results. The American College of Obstetricians and Gynecologists (ACOG) notes that a fetal fraction below 4% is the most common reason for a no-result report.

So her advice to wait until 11 weeks is reasonable. Her claim that results are essentially never wrong is where the science parts ways with her anecdote.

What did they get wrong (or right)?

She got the core biology right. NIPT is a chromosomal analysis, timing does affect result quality, and the test is genuinely useful for early sex determination alongside its primary purpose of screening for aneuploidies. Credit where it is due.

What she gets wrong, or at least overstates, is the error rate framing. Saying "I haven't seen anything come back wrong" is an anecdote from one clinic's patient population. It is not evidence that errors do not occur. False sex assignments do happen, most commonly in cases of vanishing twin syndrome, maternal sex chromosome mosaicism, or very low fetal fraction. A 2021 study by Hartwig et al. in Prenatal Diagnosis documented cases where NIPT incorrectly reported male sex in female fetuses due to maternal mosaic conditions. The creator briefly acknowledges internet reports of errors but dismisses them too quickly. Those reports often have biological explanations that do not reflect lab failure, but they are real and deserve more than a shrug.

Her conflation of "inconclusive" with "wrong" is also worth flagging. An inconclusive result is a quality control signal, not an error. They are different problems with different causes.

What should you actually know?

NIPT is one of the most accurate prenatal screening tools available, but it is a screening test, not a diagnostic test. That distinction matters. A positive NIPT result for a chromosomal abnormality should always be followed by confirmatory diagnostic testing like amniocentesis or chorionic villus sampling. For fetal sex, the accuracy is genuinely high after 10 weeks, but "high" still means a small percentage of results can be incorrect.

If you receive a sex result from NIPT that surprises you at the anatomy ultrasound around 18 to 20 weeks, do not panic. Ask your provider to review the original fetal fraction percentage and whether any flags appeared on the report. Low fetal fraction is the most common culprit for inaccurate sex calls.

  • NIPT is offered starting at 10 weeks, with most labs recommending 10 weeks as the minimum and accuracy improving slightly through weeks 11 to 13.
  • The test requires a maternal blood draw and analyzes cell-free fetal DNA circulating in maternal blood.
  • Insurance coverage varies significantly. Not all plans cover NIPT for low-risk pregnancies.
  • Fetal sex results from NIPT are not the same as a clinical diagnosis of a gender identity. The test identifies chromosomal sex, specifically XX or XY.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Natalie | That Ultrasound Tech · TikTok creator

958.1K views on this video

Replying to @courtneybarnard3 my take on the gender results with the blood test :) #ultrasoundtech #obgyn #pregnancy #genderreveal

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nipt fetal sex accuracy exceeds 98% after 10 weeks gestation?

NIPT fetal sex accuracy exceeds 98% after 10 weeks gestation per a 2019 systematic review by Meng et al. in Ultrasound in Obstetrics and Gynecology, but that still leaves a measurable error rate.

What does the video say about the most common cause of incorrect nipt sex results?

The most common cause of incorrect NIPT sex results is not lab failure. It is low fetal fraction, vanishing twin syndrome, or maternal sex chromosome mosaicism per Hartwig et al., 2021, Prenatal Diagnosis.

What does the video say about acog considers a fetal fraction below 4% the primary driver?

ACOG considers a fetal fraction below 4% the primary driver of no-call results, which is why testing before 10 weeks increases the chance of an inconclusive report.

What does the video say about nipt?

NIPT is a screening tool, not a diagnostic test. Chromosomal abnormality findings require confirmation via amniocentesis or CVS before clinical decisions are made.

What does the video say about fetal sex identified by nipt reflects chromosomal sex (xx?

Fetal sex identified by NIPT reflects chromosomal sex (XX or XY) and is not a statement about gender identity.

What does the video say about insurance coverage for nipt in low-risk pregnancies varies widely. patients?

Insurance coverage for NIPT in low-risk pregnancies varies widely. Patients should confirm coverage before ordering the test to avoid unexpected out-of-pocket costs.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Natalie | That Ultrasound Tech, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.